PRSS55 | Protease, serine, 55 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
RP1L1 | Retinitis pigmentosa 1-like 1 | | | | | | Not detected |
C8orf74 | Chromosome 8 open reading frame 74 | | | | | | Tissue enriched |
SOX7 | SRY (sex determining region Y)-box 7 | Transcription factors
| | | | | Mixed |
SOX7 | Transcription factor SOX-7; Uncharacterized protein; cDNA FLJ58508, highly similar to Transcription factor SOX-7 | | | | | | |
PINX1 | PIN2/TERF1 interacting, telomerase inhibitor 1 | | | | | | Expressed in all |
XKR6 | XK, Kell blood group complex subunit-related family, member 6 | Predicted membrane proteins
| | | | | Mixed |
AF131215.5 | | | | | | | Not detected |
MTMR9 | Myotubularin related protein 9 | Plasma proteins
| | | | | Expressed in all |
SLC35G5 | Solute carrier family 35, member G5 | Predicted membrane proteins Transporters
| | | | | Not detected |
C8orf12 | Chromosome 8 open reading frame 12 | | | | | | Tissue enhanced |
FAM167A | Family with sequence similarity 167, member A | | | | | | Tissue enhanced |
BLK | B lymphoid tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
GATA4 | GATA binding protein 4 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
C8orf49 | Chromosome 8 open reading frame 49 | Predicted membrane proteins
| | | | | Tissue enhanced |
NEIL2 | Nei endonuclease VIII-like 2 (E. coli) | Enzymes
| | | | | Expressed in all |
FDFT1 | Farnesyl-diphosphate farnesyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
RP11-297N6.4 | Uncharacterized protein | Predicted secreted proteins
| | | | | Mixed |
CTSB | Cathepsin B | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
DEFB136 | Defensin, beta 136 | Predicted secreted proteins
| | | | | Not detected |
DEFB135 | Defensin, beta 135 | Predicted secreted proteins
| | | | | Not detected |
DEFB134 | Defensin, beta 134 | Predicted secreted proteins
| | | | | Tissue enriched |
RP11-481A20.11 | Protein LOC101060662 | | | | | | Tissue enhanced |
DEFB130 | Beta-defensin 130-like precursor | Predicted secreted proteins
| | | | | Not detected |
ZNF705D | Zinc finger protein 705D | Transcription factors
| | | | | Not detected |
USP17L2 | Ubiquitin specific peptidase 17-like family member 2 | Enzymes
| | | | | Not detected |
FAM86B1 | Family with sequence similarity 86, member B1 | | | | | | Tissue enhanced |
DEFB130 | Defensin, beta 130 | Predicted secreted proteins
| | | | | Not detected |
FAM86B2 | Family with sequence similarity 86, member B2 | | | | | | Tissue enhanced |
LONRF1 | LON peptidase N-terminal domain and ring finger 1 | | | | | | Expressed in all |
KIAA1456 | KIAA1456 | | | | | | Tissue enriched |
DLC1 | Deleted in liver cancer 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
C8orf48 | Chromosome 8 open reading frame 48 | | | | | | Tissue enhanced |
SGCZ | Sarcoglycan, zeta | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TUSC3 | Tumor suppressor candidate 3 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
MSR1 | Macrophage scavenger receptor 1 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FGF20 | Fibroblast growth factor 20 | Plasma proteins RAS pathway related proteins
| | | | | Not detected |
MICU3 | Mitochondrial calcium uptake family, member 3 | Predicted membrane proteins
| | | | | Mixed |
ZDHHC2 | Zinc finger, DHHC-type containing 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CNOT7 | CCR4-NOT transcription complex, subunit 7 | Enzymes
| | | | | Expressed in all |
VPS37A | Vacuolar protein sorting 37 homolog A (S. cerevisiae) | Disease related genes
| | | | | Expressed in all |
MTMR7 | Myotubularin related protein 7 | | | | | | Tissue enhanced |
SLC7A2 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
PDGFRL | Platelet-derived growth factor receptor-like | Disease related genes Predicted secreted proteins
| | | | | Mixed |
MTUS1 | Microtubule associated tumor suppressor 1 | Disease related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
FGL1 | Fibrinogen-like 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PCM1 | Pericentriolar material 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
NAT1 | N-acetyltransferase 1 (arylamine N-acetyltransferase) | Enzymes
| | | | | Mixed |
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | Cancer-related genes Enzymes
| | | | | Group enriched |